The competition's heating up over a $35 billion market to treat NASH, a 'silent disease' millions are living with. But the early results look mixed.

Media coverage

• Title	The competition's heating up over a $35 billion market to treat NASH, a 'silent disease' millions are living with. But the early results look mixed.
  Media name/outlet	Business Insider UK
  Country/Territory	United Kingdom
  Date	19/02/19
  URL	https://www.businessinsider.com/nash-liver-disease-drug-development-links-to-genetics-and-microbiome-2018-4?r=UK&IR=T
  Persons	Scott Friedman

• Title	The competition's heating up over a $35 billion market to treat NASH, a 'silent disease' millions are living with. But the early results look mixed.
  Media name/outlet	Bloglikes.com
  Country/Territory	United States
  Date	19/02/19
  URL	https://www.bloglikes.com/blogs/2019-02-19/the-competition-s-heating-up-over-a-35-billion-market-to-treat-nash-a-silent-disease-millions-are-living-with-but-the-early-results-look-mixed
  Persons	Scott Friedman